NovaBay Pharmaceuticals, Inc.
NBY
$1.03
$0.4371.67%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 131.17% | 132.94% | 25.07% | 26.34% | 11.99% |
| Total Depreciation and Amortization | -24.73% | -23.69% | 5.62% | -2.08% | -7.84% |
| Total Amortization of Deferred Charges | -90.10% | -76.96% | -48.28% | 28.87% | 328.67% |
| Total Other Non-Cash Items | -88.98% | -76.03% | -32.63% | -29.00% | 4.84% |
| Change in Net Operating Assets | -249.53% | 283.12% | -46.42% | -199.48% | 250.00% |
| Cash from Operations | 252.47% | 264.35% | 6.75% | 17.15% | 61.15% |
| Capital Expenditure | 66.67% | 75.00% | 78.95% | 56.25% | 93.68% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 66.67% | 75.00% | 78.95% | 56.25% | 93.68% |
| Total Debt Issued | -- | -83.33% | -83.33% | -100.00% | -100.00% |
| Total Debt Repaid | 47.72% | 6.48% | -35.01% | -249.87% | -1,185.49% |
| Issuance of Common Stock | 341.59% | 558.23% | 449.56% | -- | -53.55% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -99,350.00% | -855.50% | 36.46% | 99.32% | 99.32% |
| Cash from Financing | 141.78% | -70.37% | -21.47% | -80.41% | -123.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -59.74% | -57.58% | -57.58% | 301.37% | 2,056.25% |
| Net Change in Cash | 219.23% | 412.12% | -10.34% | -614.52% | -588.96% |